Capricor Therapeutics, Inc. SEC filings CAPR
Capricor Therapeutics, Inc. has 963 filings in SEC EDGAR's recent list, going back to Feb 7, 2001. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 24, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 10, 2026 | Jun 4, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 31, 2026 | May 22, 2025 |
| DEF 14A | Proxy statement | Apr 8, 2025 | May 22, 2025 |
| DEF 14A | Proxy statement | Apr 1, 2024 | May 14, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 20, 2024 | May 14, 2024 |
| DEF 14A | Proxy statement | Apr 17, 2023 | — |
| PRE 14A | Preliminary proxy statement | Apr 7, 2023 | — |
| DEF 14A | Proxy statement | Apr 12, 2022 | Jun 3, 2022 |
| DEF 14A | Proxy statement | Apr 20, 2021 | Jun 11, 2021 |
| DEF 14A | Proxy statement | Apr 17, 2020 | Jun 5, 2020 |
| DEF 14A | Proxy statement | Apr 30, 2019 | May 29, 2019 |
| PRE 14A | Preliminary proxy statement | Apr 19, 2019 | May 29, 2019 |
| DEF 14A | Proxy statement | Apr 26, 2018 | Jun 8, 2018 |
| DEF 14A | Proxy statement | Apr 21, 2017 | Jun 14, 2017 |
| DEF 14A | Proxy statement | Apr 28, 2016 | Jun 2, 2016 |
| DEF 14A | Proxy statement | May 18, 2015 | Jun 8, 2015 |
| DEF 14A | Proxy statement | Sep 17, 2014 | Nov 4, 2014 |
| DEF 14A | Proxy statement | Oct 10, 2013 | Nov 12, 2013 |
| PRE 14A | Preliminary proxy statement | Sep 27, 2013 | Sep 27, 2013 |
| DEF 14A | Proxy statement | Apr 8, 2011 | May 10, 2011 |
| PRE 14A | Preliminary proxy statement | Mar 15, 2011 | Mar 15, 2011 |
| DEF 14A | Proxy statement | Jun 15, 2010 | Jul 26, 2010 |
| DEF 14A | Proxy statement | Nov 2, 2009 | Dec 10, 2009 |
| DEF 14A | Proxy statement | Apr 18, 2008 | May 29, 2008 |
| DEF 14C | Information statement | Oct 19, 2006 | Oct 20, 2006 |
| PRE 14C | Filing | Oct 6, 2006 | Oct 6, 2006 |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CAPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1133869
- Former names
- Nile Therapeutics, Inc. (until Nov 20, 2013); SMI PRODUCTS INC (until Sep 19, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.